SLO's 4th Investors Event
Our fourth investors’ event, this time in collaboration with Epstein Rosenblum Maoz Law Offices featuring medical device and pharmaceutical technology, was a great success.
We were honored by the attendance of the Taiwanese Ambassador to Israel, Mr. Chang Liang-jen, and the fascinating presentations of the following companies:
HQL Pharmaceuticals, a biotech company which utilizes its breakthrough proprietary computational technology to fundamentally change the way drug discovery is conducted.
Drink Sciences is developing a single-use kit for the detection of drugs in food and beverage. The company’s technology is based on a unique technology platform and intellectual property, and exhibit a validated, highly accurate working prototype.
EZTack Medical is developing a variety of minimally invasive tools based on its patented Drive Platform which allows delivering torque through 5mm articulated shafts, facing the multi-billion dollar minimally invasive surgery market.
Human Extensions is developing a hand-held robotic powered intelligent system for the Minimally Invasive Surgery (MIS) market. The company’s new concept allows surgeons, for the first time since open surgery, to control surgery as if they have the use of their own hands inside the patient’s body.
Mobile OCT has developed a unique compound lens that can upgrade any digital camera – even and especially that on a smartphone – into a sophisticated cancer screening device.
We would like to thank everyone who attended and helped make this such a successful event.
Stay tuned for our next event!